Are You in Florida for Spring Training? Come meet Globe Sports Writers Nick Cafardo and Peter Abraham! Click for more info.

Ariad adds activist investor to board

Activist investor Alexander J. Denner has been named to a two-year term on the board of Cambridge biotech Ariad Pharmaceuticals Inc., the company said Friday.

Denner, a protege of Carl C. Icahn and veteran of many battles with biotechnology managers, recently founded his own hedge fund, Sarissa Capital Management of Greenwich, Conn. The fund bought a 6.2 percent stake in Ariad last October, according to a regulatory filing, and Denner has been agitating for a seat on Ariad’s board.

Continue reading below

The company, which lost more than half its stock value last year amid safety concerns over its blood cancer drug Iclusig, has been a rumored takeover candidate. Denner’s appointment boosts the number of Ariad directors to nine. Ariad said it plans to add a 10th.

Neither Denner nor an Ariad representative immediately responded to requests for comment.

Robert Weisman can be reached at robert.weisman@globe.com. Follow him on Twitter @GlobeRobW.
Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com